Search results
Tesla shareholders to vote today on $56B pay package
TechCrunch· 1 day agoKirsten Korosec is still off on holiday, so you’ve got me once again! Today is the big Tesla shareholder vote. You’ve probably seen the breathless and...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
Ipsen drug for rare liver disease approved by FDA
BioPharma Dive via Yahoo Finance· 3 days agoThe medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...
Ozy Media went from buzzy to belly-up. Its founder, Carlos Watson, is now on trial
Associated Press· 2 days agoFor nearly a decade, Ozy Media projected an image of new-media success. The company boasted big-name...
Russia accused of using hunger as a weapon of war in Ukraine
WKBT La Crosse· 1 day agoIt found that Russian forces “systematically attacked objects indispensable to the survival of the...
Seeing Project G-Assist in action made us want NVIDIA's AI Assistant for all our PC gaming
TweakTown· 2 days agoLike DLSS, Project G-Assist is a general LLM or AI model trained on a broad range of titles, and...
FDA grants Shattuck Labs orphan drug status for AML treatment By Investing.com
Investing.com· 4 days agoShattuck Labs, Inc. (NASDAQ:STTK), a biotechnology firm engaged in the development of fusion...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
AOL· 4 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver disease, Iqirvo ...
Check out some of the best conceptual stories heard on Hip Hop albums
Revolt via Yahoo News· 3 days agoHip Hop concept albums that tell a story represent a unique and immersive way for artists to convey...
FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC
Medscape· 4 days agoIqirvo (elafibranor) is indicated for adults with primary biliary cholangitis who do not respond to or cannot tolerate ursodeoxycholic acid.